DE69107488D1 - Di- oder Tetrafluoranaloga von Squalen als Inhibitoren der Squalenepoxidase. - Google Patents

Di- oder Tetrafluoranaloga von Squalen als Inhibitoren der Squalenepoxidase.

Info

Publication number
DE69107488D1
DE69107488D1 DE69107488T DE69107488T DE69107488D1 DE 69107488 D1 DE69107488 D1 DE 69107488D1 DE 69107488 T DE69107488 T DE 69107488T DE 69107488 T DE69107488 T DE 69107488T DE 69107488 D1 DE69107488 D1 DE 69107488D1
Authority
DE
Germany
Prior art keywords
squalene
tetrafluoro
analogues
inhibitors
epoxidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69107488T
Other languages
English (en)
Other versions
DE69107488T2 (de
Inventor
Esa T Jarvi
James R Mccarthy
Michael L Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69107488D1 publication Critical patent/DE69107488D1/de
Application granted granted Critical
Publication of DE69107488T2 publication Critical patent/DE69107488T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C21/00—Acyclic unsaturated compounds containing halogen atoms
    • C07C21/02—Acyclic unsaturated compounds containing halogen atoms containing carbon-to-carbon double bonds
    • C07C21/215—Halogenated polyenes with more than two carbon-to-carbon double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
DE69107488T 1990-03-30 1991-01-28 Di- oder Tetrafluoranaloga von Squalen als Inhibitoren der Squalenepoxidase. Expired - Fee Related DE69107488T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/502,203 US5011859A (en) 1990-03-30 1990-03-30 Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase

Publications (2)

Publication Number Publication Date
DE69107488D1 true DE69107488D1 (de) 1995-03-30
DE69107488T2 DE69107488T2 (de) 1995-06-14

Family

ID=23996803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69107488T Expired - Fee Related DE69107488T2 (de) 1990-03-30 1991-01-28 Di- oder Tetrafluoranaloga von Squalen als Inhibitoren der Squalenepoxidase.

Country Status (19)

Country Link
US (1) US5011859A (de)
EP (1) EP0448934B1 (de)
JP (1) JP2911239B2 (de)
KR (1) KR0162659B1 (de)
CN (1) CN1055172A (de)
AT (1) ATE118756T1 (de)
AU (1) AU629726B2 (de)
CA (1) CA2034612C (de)
DE (1) DE69107488T2 (de)
ES (1) ES2071131T3 (de)
FI (1) FI910425A (de)
HU (1) HU208103B (de)
IE (1) IE910181A1 (de)
IL (1) IL97356A0 (de)
NO (1) NO910263L (de)
NZ (1) NZ236800A (de)
PH (1) PH27365A (de)
PT (1) PT96654A (de)
ZA (1) ZA91392B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7238394A (en) * 1993-07-29 1995-02-28 Chugai Seiyaku Kabushiki Kaisha Tricarboxylic acid derivative having squalene synthetase inhibitor activity
DE19754795A1 (de) * 1997-12-10 1999-06-17 Boehringer Ingelheim Pharma Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CL2007002958A1 (es) * 2006-10-12 2008-05-09 Epix Delaware Inc Compuestos derivados de heteroaril-carboxamida, antagonistas del receptor de quimioquina; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades tales como rechazo de transplante de organos, artritis reumatoidea, lupus, entr
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
US20100331298A1 (en) * 2007-12-10 2010-12-30 Cytopathfinder, Inc. Carboxamide Compounds and Their Use
EP2280766A1 (de) 2007-12-11 2011-02-09 CytoPathfinder, Inc. Carboxamid-verbindungen und ihre verwendung als chemokin-rezeptor-agonisten
US20130072519A1 (en) 2010-05-21 2013-03-21 Edward Lee Conn 2-phenyl benzoylamides
EP2680874A2 (de) 2011-03-04 2014-01-08 Pfizer Inc Edn3-ähnliche peptide und ihre verwendung
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JP7128969B2 (ja) 2019-01-18 2022-08-31 アストラゼネカ・アクチエボラーグ Ｐｃｓｋ９阻害剤及びその使用方法
CN112678833B (zh) * 2020-11-17 2023-08-04 广西中烟工业有限责任公司 纳米二氧化硅改性角鲨烯有机硅颗粒及其制备和使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876672A (en) * 1972-02-21 1975-04-08 Du Pont Hydroformylation of olefins
DE2913677C2 (de) * 1979-04-05 1983-03-03 Union Rheinische Braunkohlen Kraftstoff AG, 5000 Köln Verfahren zur Herstellung von Acetaldehyddimethylacetal
US4455441A (en) * 1982-09-24 1984-06-19 Research Foundation Of State University Of New York Attractant termiticidal compounds, compositions and methods of use therefor
DE3618115A1 (de) * 1986-05-30 1987-12-03 Bayer Ag Halogenolefine
US4876295A (en) * 1987-03-11 1989-10-24 The Dow Chemical Company Flexible thermoplastic epoxy resin and coatings prepared therefrom

Also Published As

Publication number Publication date
ES2071131T3 (es) 1995-06-16
CA2034612C (en) 2001-05-15
PH27365A (en) 1993-06-21
CN1055172A (zh) 1991-10-09
EP0448934B1 (de) 1995-02-22
EP0448934A2 (de) 1991-10-02
FI910425A (fi) 1991-10-01
NZ236800A (en) 1993-05-26
US5011859A (en) 1991-04-30
IL97356A0 (en) 1992-05-25
AU6946891A (en) 1991-10-03
HUT56533A (en) 1991-09-30
NO910263L (no) 1991-10-01
AU629726B2 (en) 1992-10-08
HU208103B (en) 1993-08-30
EP0448934A3 (en) 1991-11-27
JP2911239B2 (ja) 1999-06-23
JPH04221327A (ja) 1992-08-11
ATE118756T1 (de) 1995-03-15
FI910425A0 (fi) 1991-01-29
KR910016660A (ko) 1991-11-05
KR0162659B1 (ko) 1999-01-15
HU910174D0 (en) 1991-08-28
CA2034612A1 (en) 1991-10-01
PT96654A (pt) 1991-10-31
NO910263D0 (no) 1991-01-23
ZA91392B (en) 1991-10-30
DE69107488T2 (de) 1995-06-14
IE910181A1 (en) 1991-10-09

Similar Documents

Publication Publication Date Title
DE69107488D1 (de) Di- oder Tetrafluoranaloga von Squalen als Inhibitoren der Squalenepoxidase.
DE69530004D1 (de) Transdermale verabreichung von apomorphin
DK0605501T3 (da) Fremgangsmåde og sammensætninger til behandling af cerebral parese
ES2182863T3 (es) Ranolazina y piperazinas relacionadas para proteger musculos esqueleticos.
DE69212326D1 (de) Azeotropische zusammensetzungen von 1,1,1,2,3,4,4,5,5,5 decafluoropentan und trans-1,2-dichlorethylen, cis-1,2-dichlorethylen oder 1,1-dichlorethan
IT1232889B (it) Composizioni e procedimento per il trattamento ammorbidente di tessuti
DE69225426D1 (de) Neue Thrombin-Inhibitoren
ATE161013T1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DE3785808D1 (de) Mischungen von dicyanatestern von dihydroxyphenolen.
ATE306473T1 (de) Neue piperazinyl-substituierte pyridylalkan, alken and alkin carboxamide
DE69118526D1 (de) Mittel zur transdermalen penetration von arzneimitteln
ATE159542T1 (de) Zusammensetzung zum entfernen von kesselstein
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
DE3887861D1 (de) Vewendung von Aminen als Wärmestabilisierungsmittel in Organosiloxanzusammen-setzungen.
DE69102936D1 (de) Bis(alkyl-substituierte-4-hydroxyphenylthio)alkan-Analoga als Inhibitoren der Kataraktentstehung.
ATE70447T1 (de) Transdermal anwendbare pharmazeutische zubereitungen mit sterolen und/oder spiroketalinen.
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
DE68903196D1 (de) Behandlung von grundplatten fuer leiterplatten.
NO304874B1 (no) Anvendelse av kolesterolnedsettende tokoferolanaloger
ATE244011T1 (de) Unterdrückung der thromboxanspiegel durch perkutane verabreichung von aspirin
DE68927144D1 (de) Impfstoff gegen Bordetella pertussis
DE59100889D1 (de) Verfahren zum Verdampfen von flüssigem Erdgas.
DE69213586D1 (de) Verfahren zum Stabilisieren von Dibenzylidenesorbitolen und Zusammensetzungen davon
FR2308498A1 (fr) Elements tels que baignoires et analogues, presentant l'aspect du marbre

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee